JNBY (03306) plans to offer a discount of approximately 9.01% for the placement of 14.535 million shares. The net proceeds are estimated to be around HK$270 million.
Jiangnan Cloth (03306) announced that on January 23, 2026 (before the trading hours of the Stock Exchange), the company entered into an placing agreement with the placing agent, whereby the company agreed to appoint the placing agent to act as its agent and the placing agent agreed to use its best efforts to promote that not less than 6 placees subscribe for 14.535 million placing shares at a placing price of HK$18.78 per share in accordance with the terms of the placing agreement and subject to the conditions therein.
JNBY (03306) announces that on January 23, 2026 (before the trading hours of the Stock Exchange), the company entered into a placement agreement with the placing agent. Under this agreement, the company appointed the placing agent to act as its agent and the placing agent agreed to use their best efforts to facilitate the subscription of no less than 6 underwriters to purchase 14.53 million shares at a placement price of HK$18.78 per share.
The number of shares being placed represents approximately (a) 2.80% of the total issued shares as of the date of this announcement; and (b) approximately 2.73% of the total issued shares after the completion of the placement (assuming no change in the total issued shares from the date of this announcement to the completion of the placement, other than the issuance of the placement shares). The placement price represents a discount of approximately 9.01% to the closing price of HK$20.64 per share on the Stock Exchange on January 22, 2026 (the business day immediately preceding the date of the placement agreement).
If all the placement shares are fully subscribed and allotted, the total expected proceeds from the placement are approximately HK$273 million, and the net proceeds (after deducting all relevant costs and expenses, including commissions and fees) are estimated to be approximately HK$270 million. Based on this calculation, the net price per placement share will be approximately HK$18.58. The net proceeds from the placement will be used for (i) enhancing brand development; (ii) research and development investments to further enhance overall market competitiveness; and (iii) general and corporate purposes.
Related Articles

INSILICO (03696): AI-driven NLRP3 inhibitor ISM8969 clinical trial application approved by FDA Has "best-in-class" potential
.png)
Hydsoft Technology (301316.SZ) issued shares to purchase assets and raised funds for matching, the application documents have been accepted by the Shenzhen Stock Exchange.

Zhongjin: European and American trade relations under geopolitical disputes.
INSILICO (03696): AI-driven NLRP3 inhibitor ISM8969 clinical trial application approved by FDA Has "best-in-class" potential

Hydsoft Technology (301316.SZ) issued shares to purchase assets and raised funds for matching, the application documents have been accepted by the Shenzhen Stock Exchange.
.png)
Zhongjin: European and American trade relations under geopolitical disputes.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


